載入...
Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma
Antibodies targeting CD38 are rapidly changing the treatment landscape of multiple myeloma (MM). CD38−directed antibodies have several mechanisms of action. Fc−dependent immune effector mechanisms include complement-dependent cytotoxicity (CDC), antibody−dependent cell−mediated cytotoxicity (ADCC),...
Na minha lista:
| 發表在: | J Clin Med |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7230744/ https://ncbi.nlm.nih.gov/pubmed/32331242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9041195 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|